Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Søe

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Scandinavian Journal of Gastroenterology|December 17, 1997
Intestinal obstruction after appendectomyC Riber, K Søe, T Jørgensen, et al.
Oncogene|June 27, 2006
Cellular stress triggers the human topoisomerase I damage response independently of DNA damage in a p53 controlled mannerA Rockstroh, A Kleinert, M Kramer, et al.
Nucleic Acids Research|July 27, 2001
A human topoisomerase I cleavage complex is recognized by an additional human topisomerase I molecule in vitroK Søe, G Dianov, H P Nasheuer, et al.
Hematological Oncology|August 1, 2008
A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myelomaT E Sondergaard, P T Pedersen, T L Andersen, et al.
Journal of Dental Research|February 7, 2023
HBP/O-GlcNAcylation Metabolic Axis Regulates Bone Resorption OutcomeT M Taira, E S Ramos-Junior, P H Melo, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Scandinavian Journal of Gastroenterology|December 17, 1997
Intestinal obstruction after appendectomyC Riber, K Søe, T Jørgensen, et al.
Oncogene|June 27, 2006
Cellular stress triggers the human topoisomerase I damage response independently of DNA damage in a p53 controlled mannerA Rockstroh, A Kleinert, M Kramer, et al.
Nucleic Acids Research|July 27, 2001
A human topoisomerase I cleavage complex is recognized by an additional human topisomerase I molecule in vitroK Søe, G Dianov, H P Nasheuer, et al.
Hematological Oncology|August 1, 2008
A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myelomaT E Sondergaard, P T Pedersen, T L Andersen, et al.
Journal of Dental Research|February 7, 2023
HBP/O-GlcNAcylation Metabolic Axis Regulates Bone Resorption OutcomeT M Taira, E S Ramos-Junior, P H Melo, et al.
Pageof 1